156 related articles for article (PubMed ID: 29698701)
1. Mucinous intrahepatic cholangiocarcinoma: a distinct variant.
Chi Z; Bhalla A; Saeed O; Cheng L; Curless K; Wang HL; Patil DT; Lin J
Hum Pathol; 2018 Aug; 78():131-137. PubMed ID: 29698701
[TBL] [Abstract][Full Text] [Related]
2. [Expression of mucin glycoproteins and cytokeratins in intrahepatic cholangiocarcinoma].
Zhao SM; Zhu XZ; Ji Y; Hou J
Zhonghua Bing Li Xue Za Zhi; 2008 Nov; 37(11):749-53. PubMed ID: 19094709
[TBL] [Abstract][Full Text] [Related]
3. Expression of MUC1, MUC2, MUC5AC and MUC6 in cholangiocarcinoma: prognostic impact.
Park SY; Roh SJ; Kim YN; Kim SZ; Park HS; Jang KY; Chung MJ; Kang MJ; Lee DG; Moon WS
Oncol Rep; 2009 Sep; 22(3):649-57. PubMed ID: 19639217
[TBL] [Abstract][Full Text] [Related]
4. Pathological aspects of mucinous cholangiocarcinoma: A single-center experience and systematic review.
Laohawetwanit T; Klaikaew N
Pathol Int; 2020 Sep; 70(9):661-670. PubMed ID: 32638458
[TBL] [Abstract][Full Text] [Related]
5. Aberrant expression of CDX2 is closely related to the intestinal metaplasia and MUC2 expression in intraductal papillary neoplasm of the liver in hepatolithiasis.
Ishikawa A; Sasaki M; Ohira S; Ohta T; Oda K; Nimura Y; Chen MF; Jan YY; Yeh TS; Nakanuma Y
Lab Invest; 2004 May; 84(5):629-38. PubMed ID: 15048136
[TBL] [Abstract][Full Text] [Related]
6. Bim is an independent prognostic marker in intrahepatic cholangiocarcinoma.
Zhang H; Jenkins SM; Lee CT; Harrington SM; Liu Z; Dong H; Zhang L
Hum Pathol; 2018 Aug; 78():97-105. PubMed ID: 29698699
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological, radiologic, and molecular study of 23 combined hepatocellular-cholangiocarcinomas with stem cell features, cholangiolocellular type.
Chen J; He J; Deng M; Wu HY; Shi J; Mao L; Sun Q; Tang M; Fan XS; Qiu YD; Huang Q
Hum Pathol; 2017 Jun; 64():118-127. PubMed ID: 28431889
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical distinction between intrahepatic cholangiocarcinoma and pancreatic ductal adenocarcinoma.
Lok T; Chen L; Lin F; Wang HL
Hum Pathol; 2014 Feb; 45(2):394-400. PubMed ID: 24439226
[TBL] [Abstract][Full Text] [Related]
9. Mucinous carcinomas of the gallbladder: clinicopathologic analysis of 15 cases identified in 606 carcinomas.
Dursun N; Escalona OT; Roa JC; Basturk O; Bagci P; Cakir A; Cheng J; Sarmiento J; Losada H; Kong SY; Ducato L; Goodman M; Adsay NV
Arch Pathol Lab Med; 2012 Nov; 136(11):1347-58. PubMed ID: 23106580
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological analysis of colorectal cancer liver metastasis and intrahepatic cholangiocarcinoma: are they just apples and oranges?
Chiu CT; Chiang JM; Yeh TS; Tseng JH; Chen TC; Jan YY; Chen MF
Dig Liver Dis; 2008 Sep; 40(9):749-54. PubMed ID: 18329969
[TBL] [Abstract][Full Text] [Related]
11. Two distinct pathways of carcinogenesis in primary sclerosing cholangitis.
Zen Y; Quaglia A; Heaton N; Rela M; Portmann B
Histopathology; 2011 Dec; 59(6):1100-10. PubMed ID: 22175890
[TBL] [Abstract][Full Text] [Related]
12. [Intraductal papillary mucinous cholangiocarcinoma].
Han JK; Kim SH; Kim SJ
Korean J Hepatol; 2007 Jun; 13(2):243-7. PubMed ID: 17585199
[No Abstract] [Full Text] [Related]
13. The utility of villin and mammaglobin in the differential diagnosis between intrahepatic cholangiocarcinoma and breast cancer.
Yang Z
Appl Immunohistochem Mol Morphol; 2015 Jan; 23(1):19-25. PubMed ID: 25153498
[TBL] [Abstract][Full Text] [Related]
14. Distinct clinical and prognostic implication of IDH1/2 mutation and other most frequent mutations in large duct and small duct subtypes of intrahepatic cholangiocarcinoma.
Ma B; Meng H; Tian Y; Wang Y; Song T; Zhang T; Wu Q; Cui Y; Li H; Zhang W; Li Q
BMC Cancer; 2020 Apr; 20(1):318. PubMed ID: 32293336
[TBL] [Abstract][Full Text] [Related]
15. Intraductal papillary mucininous neoplasm of the bile ducts: multimodality assessment with pathologic correlation.
Takanami K; Yamada T; Tsuda M; Takase K; Ishida K; Nakamura Y; Kanno A; Shimosegawa T; Unno M; Takahashi S
Abdom Imaging; 2011 Aug; 36(4):447-56. PubMed ID: 20959978
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological Features and Prognosis of Intrahepatic Cholangiocarcinoma After Liver Transplantation and Resection.
Jung DH; Hwang S; Song GW; Ahn CS; Moon DB; Kim KH; Ha TY; Park GC; Hong SM; Kim WJ; Kang WH; Kim SH; Yu ES; Lee SG
Ann Transplant; 2017 Jan; 22():42-52. PubMed ID: 28123170
[TBL] [Abstract][Full Text] [Related]
17. Intrahepatic cholangiocarcinoma frequently shows loss of BAP1 and PBRM1 expression, and demonstrates specific clinicopathological and genetic characteristics with BAP1 loss.
Misumi K; Hayashi A; Shibahara J; Arita J; Sakamoto Y; Hasegawa K; Kokudo N; Fukayama M
Histopathology; 2017 Apr; 70(5):766-774. PubMed ID: 27864835
[TBL] [Abstract][Full Text] [Related]
18. Intrahepatic intraductal cholangiocarcinoma.
Han JK; Lee JM
Abdom Imaging; 2004; 29(5):558-64. PubMed ID: 15185024
[No Abstract] [Full Text] [Related]
19. A case of mucinous cholangiocarcinoma showing features of hepatocellular carcinoma.
Kai K; Ide Y; Miyoshi A; Masuda M; Ide T; Kitahara K; Irie H; Nakajima J; Noshiro H; Tokunaga O
Pathol Int; 2013 Aug; 63(8):419-21. PubMed ID: 23957918
[No Abstract] [Full Text] [Related]
20. Expression of MUC1 and MUC2 mucin antigens in intrahepatic bile duct tumors: its relationship with a new morphological classification of cholangiocarcinoma.
Higashi M; Yonezawa S; Ho JJ; Tanaka S; Irimura T; Kim YS; Sato E
Hepatology; 1999 Dec; 30(6):1347-55. PubMed ID: 10573510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
